can shift oxylipin production toward anti-inflammatory mediators, such as resolvins and protectins derived from omega-3 fatty acids, which reduce obesity risk by mitigating inflammation (Tables 1 and 2). The gene discussed is CD59; the disease is obesity due to melanocortin 4 receptor deficiency.